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Abstract
Background: The aim was to evaluate the geometric and corresponding dosimetric differences between two
delineation strategies for head and neck tumors neighboring air cavities.
Methods: Primary gross and clinical tumor volumes (GTV and CTV) of 14 patients with oropharynx or larynx tumors
were contoured using a soft tissue window (S). In a second strategy, the same volumes were contoured with an
extension to include the parts which became visible on lung window (L). For the calculation of Hausdorff-distances
(HD) between contoured volumes of the two strategies, triangular meshes were exported. Two radiotherapy plans
with identical goals and optimization parameters were generated for each case. Plan_S were optimized on CTV_S,
and Plan_L on CTV_L. The dose coverages of CTV_L and CTV_Δ (CTV_L minus CTV_S) were evaluated in Plan_S.
OAR doses were compared among Plan_S and Plan_L.
Results: Median three-dimensional HD for GTVs and CTVs were 5.7 (±2.6) and 9.3 (±2.8) mm, respectively. The
median volume differences between structures contoured using L and S windows were 9% (±5%) and 9% (±4%)
for GTV and CTV, respectively. In 13 out of 14 cases, Plan_S met the plan acceptance criteria for CTV_L. In 8 cases
CTV_Δ was covered insufficiently in Plan_S. Mean and median differences in OAR dose-volume histogram
parameters between Plan_S and Plan_L were within 3%.
Conclusion: For the current practice in radiotherapy planning for head and neck cancer, the delineation of L-based
volumes seems unnecessary. However, in special settings, where smaller or no PTV margins are used, this approach
may play an important role for local control.
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Introduction
Currently, there is a well-established international con-
sensus among radiation oncologists for the delineation
of the organs at risk (OARs) and the elective lymphatic
levels for the radiotherapy planning of squamous cell
head and neck cancer (SCCHN) [1, 2]. Despite the het-
erogeneity based on the equipment and institutional
protocols, image guided treatment technologies are
allowing the clinicians to reduce the margins used to
generate the planning treatment volumes (PTVs) around
the clinical target volumes (CTVs). It is difficult to fore-
cast, if and when the PTV can be abolished in the future
(i.e. CTV = PTV). Before reaching this goal, there is
another uncertainty which needs to be addressed: the
uncertainty and heterogeneity in the delineation strategy
of the high-risk CTV around the primary tumor [3].
There are different strategies to define this high-risk
CTV, most of them based on tradition, data inferred
from pathology results and patterns of failure. One
method is based on pre-defined anatomical subsites [4],
whereas the other approach uses an isotropic expansion
around the gross tumor volume (GTV), which is later
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modified by anatomical barriers (e.g. air, non-infiltrated
bone, fascia) [5]. Some radiation oncologists use a com-
bination of both strategies [6]. It is worth to note, that
the expansion margin also varies among radiation oncol-
ogists and treatment protocols. Kim et al. recently
defined the CTV as the “third front” of radiotherapy as
the field least investigated and methodologically most
difficult to investigate among the target volumes [7].
For the visualization and delineation of structures situ-
ated in the lung parenchyma, lung window (L) is recom-
mended and commonly used. It contrasts the soft-tissue
structures against neighboring and surrounding air with
higher fidelity over soft tissue window (S) [8]. The
majority of SCCHN tumors arise from the mucosa and
thus there is an air interface with the tumor. However,
to our knowledge there is no literature recommending
or investigating the use of the L for the delineation of
target volumes for SCCHN.
This work aims to investigate the geometric and dosi-
metric impact of two different contouring strategies
based on S and L in a hypothetical ‘ideal future scenario’,
where PTV would be tighter around, or preferably equal
to the CTV, if the systematic and random errors can be
minimized or eliminated somehow [9].
Methods
Planning-CT data sets of 14 previously treated SCCHN
cases with primary tumors emerging from oropharynx
or larynx were used for the study. A summary of patient
and disease characteristics are provided in Table 1.
Primary tumor GTVs were delineated using S (GTV_S).
In all GTVs an extension towards the air was revealed
by switching to L. GTVs were expanded to cover these
additional parts which created GTV_L. Using an
isotropic 8 mm margin, CTV_L was generated around
GTV_L. Air, bone and anatomical boundaries were
cropped out to finalize CTV_L. Based on GTV_S, the
same process was repeated to generate CTV_S using S
(Fig. 1). S corresponded to the default acquisition pa-
rameters used for head and neck imaging in our plan-
ning CT, and L was the default presets (Hounsfield Unit
range: -1000 – 0) in the Eclipse treatment planning system
(version 13.6, Varian Medical Systems, Palo Alto, CA).
Triangular meshes (TMs) for all volumes were
exported using the Eclipse Research Scripting API 13.6.
An analysis-tool written in Python 3.5 was used to
analyze the TMs and to calculate surfaces, volumes and
Hausdorff-distances (HDs) between the two different
contour sets. The Python scripts are available upon
request to the corresponding author.
Two volumetric modulated arc therapy plans were gen-
erated for each case. Plan_S were optimized on CTV_S,
and Plan_L on CTV_L. All plans were prescribed to
70 Gy normalized on D95%. The plan objectives (Table 2)
and optimization criteria (Additional file 1) were identical
to our institutional standards except for the use of CTV
instead of PTV. The same OARs and corresponding dose
constraints were used for the optimization of all plans (i.e.
Table 1 patient and disease characteristics
Characteristic Value
Mean age (range) 63 (50–79)
Female/male 6/8
Tumor subsite
Oropharynx 9
Supraglottic larynx 5
cT Stagea
T2 6
T3 2
T4a 6
cN Stagea
N0 3
N1 2
N2(a/b/c) 9 (0/2/7)
aUICC 7th edition. All patients were cM0
Fig. 1 Differences in target volume delineation in soft tissue and
lung windows. GTV and CTV contoured on lung window (green
structures) are slightly larger than their counterparts contoured in
soft tissue window (red structures). a: Both GTVs on soft tissue
window; b: Both GTVs on lung window; c: Both CTVs on soft tissue
window; d: Both CTVs on lung window
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geometrical differences only existing between the L- and
S-based target volumes).
To investigate any possible under-dose of the air-
tumor surface, the dose coverage of CTV_L was assessed
in Plan_S. Additionally, the dose coverage of CTV_Δ
(CTV_L minus CTV_S) was determined. In order to
quantify the dosimetric differences, OAR doses were
compared among Plan_S and Plan_L.
In this study, the geometric and dosimetric differences
between two target volume delineation strategies are
evaluated. Thus, the statistical methodology was purely
descriptive, because the differences in target volumes
and dose coverage are unidirectional, where any “statisti-
cally significant” difference can be demonstrated anyway.
Results
Volumes of the GTVs and CTVs resulted by applying
the two contouring approaches are provided in Table 3.
Median three-dimensional HD for GTVs and CTVs were
5.7 (±2.6) and 9.3 (±2.8) mm, respectively. Median two-
dimensional HD for the same structures in axial plane
were 4.7 (±2.8) and 5.2 (±3.8) mm, respectively. The me-
dian volume differences between L and S were 9% (±5%)
and 9% (±4%) for GTV and CTV, respectively.
All planning objectives were successfully met for
CTV_S in all Plan_S, and for CTV_L in all Plan_L. In 13
out of 14 cases, Plan_S met the plan acceptance criteria
for CTV_L. However, in 8 cases CTV_Δ was covered
with an inadequate dose (D98% as provided in Table 2)
in Plan_S. Dose coverage of each CTV_L and CTV_Δ on
Plan_S is provided in Table 4. Median differences in OAR
doses between Plan_S and Plan_L were up to 2.4% with a
minimum-maximum range of 0-17% (Additional file 1).
Discussion
In this in silico analysis, a median increase of 9% in target
volumes and a median three-dimensional HD close to
1 cm was observed. In over half of the cases, the CTV_Δ
was covered with an inadequate dose. However, it is un-
known whether this would reflect in a reduced tumor con-
trol probability (TCP) in reality. When looked at the dose
coverage of the whole CTV_L and not just at the differ-
ence volume CTV_Δ, only one case (number 7 in Table 4)
would receive an inadequate dose through the Plan_S.
It is worth to note, that the dosimetric results of this
study, especially doses received by the OARs, do not
reflect plan results of the current standards of practice,
mainly due to two reasons. First, in this study CTVs
instead of PTVs were used as mentioned before. Second,
in order to purely investigate the plain impact of the
L-based delineation strategy, any high risk nodal and
elective volumes were ignored. Therefore, it is difficult
to make an assumption in terms of TCP in this simu-
lated scenario. However, the results provide an insight
for extra caution possibly needed for target volume
delineation for applications like single vocal cord irradi-
ation [10] or stereotactic radiotherapy [11, 12], where
Table 2 target volume objectives for dose coverage
Objectiveb Per Protocol Variation Acceptable Deviation Unacceptable
D95% of PTV70 70 Gy (100%) ≤+/-2% >+/-2%
D5% of PTV70 ≤74.9 Gy (107%) ≤77 Gy (110%) >77 Gy (110%)
D98% of PTV70 ≥66.5 Gy (95%) ≥63 Gy (90%)
a <63 Gy (90%)a
Maximum dose (hot spot ≤0.03 cm3) outside the PTV70 ≤74.9 Gy (107%) ≤77 Gy (110%) >77 Gy (110%)
aIt is recognized that portions of the PTV close to the skin may receive significantly less than 90% of the prescribed dose. This is acceptable as long as cold spots
within PTV do not exist at a depth deeper than 5 mm beneath the skin
bCTV_S and CTV_L used instead of PTV70 for the purpose of this study
Table 3 gross and clinical tumor volumes
Structure Median Volume in cm3 (range)
GTV_S 22.5 (4.3–49.3)
GTV_L 25.4 (5.6–54.9)
CTV_S 89.7 (30.6–166.2)
CTV_L 98.4 (34.1–176.5)
Table 4 dose coverages (%) of CTV_L and CTV_Δ on Plan_S
Case CTV_L D2 CTV_L D95% CTV_L D98% CTV_Δ D98%
1 104.7 99.6 97.9 89.8a
2 104.3 99.8 98.2 96.7
3 104.5 99.7 97.9 95.6
4 104 99.6 97 94.1a
5 104.5 99.8 98.4 96.7
6 103.9 99.6 98.5 98.1
7 104.8 97.5a 94.8a 85.1a
8 104.3 99.5 97.9 94.1a
9 105 99.2 97.3 97.5
10 104.4 99.7 98.2 96.5
11 105.5 99.2 97 85.6a
12 105.7 99.4 97.3 67.1a
13 105.2 98.7 96.7 91.9a
14 105.3 99 97.1 92.5a
aconsidered as under-coverage (please be referred to the Additional file 1)
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one and relatively small target volume is used (either
primary tumor or a single lymph node and without
elective volumes).
It may be suggested, that the use of image registration
techniques with other modalities (e.g. MRI or PET) may
overcome the uncertainty whether to use S or L on
CT-based volume delineation. However, such an approach
causes additional problems. First of all, the image registra-
tion algorithms have more geometrical uncertainty than
the difference between S and L in CT, on which the radio-
therapy plan is generated. In addition to that, these
imaging modalities are not free from intrinsic uncertain-
ties caused by problems such as partial volume effect
(sometimes varying among different sequences of the
same MRI acquisition, for instance caused by different
slice thicknesses), varying tumor appearance on MRI due
to different acquisition parameters/techniques, movement
artefacts (e.g. due to swallowing during MR), different
neck positioning compared to planning CT or the lack of
agreement over ideal thresholding on PET imaging.
Presumably, the already marginal and (in our subject-
ive opinion) clinically negligible dose differences in
OARs between Plan_S and Plan_L would be even less
prominent if other high (i.e. involved lymph nodes) and
low risk/elective target volumes are to be used. By look-
ing at the overall picture, the results of this study can be
interpreted towards two opposite directions. It may be
argued that the extra effort to define a GTV_L and
CTV_L would be trivial, since CTV to PTV margins of
at least 3 mm are used. Today, less than 3-5 mm expan-
sion margins are not recommended to generate PTV
from CTV in SCCHN [13, 14], and this may blur and
rule out any delineation uncertainties occurring at the
air-tissue border, even though these suggested PTV mar-
gins do not take the CTV_Δ into account. In a practical
sense, an increased PTV expansion based on the HDs
arising from CTV_Δ would overcome this problem
without increasing the L-based delineation workload.
However, this would also unnecessarily enlarge the PTV
towards the soft tissue, even by using anisotropic mar-
gins. Although the median HD was larger than initially
expected, these geometric differences between L and S
usually occur in the ‘coves’ of the concave parts of the
target volumes neighboring cylindrical air cavities, which
are usually engulfed by PTV margins emerging from two
tips of the C-shaped volume. It is also worth to note,
that using isotropic PTV expansions on CTV_L may
increase the dose differences on OARs to a clinically
meaningful level and increase toxicity. On the contrary,
one may also argue, that the definition of these L-based
target volumes does not compromise normal tissue
doses in a clinically meaningful way, and poses a more
systematic and accurate approach, whereas omitting it
may compromise TCP, maybe not in all but some cases.
Conclusion
Currently, for the routine curative radiotherapy planning
of SCCHN, which involves elective volumes and PTV
margins, the delineation of L-based volumes seems to be
trivial. However, in special settings, where smaller or no
PTV margins are used, this approach may play an
important role for local control.
Additional file
Additional file 1: Priorities of the structures for inverse planning
optimization and detailed dose results of OARs. (XLSX 46 kb)
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